Regulus Btn

Annual Meeting Webcast Button

ADA Button

Press Release : 06-09-09
Isis Highlights New Data on Antisense Drugs to Treat Type 2 Diabetes and Obesity at ADA Scientific Sessions
> More Info

Press Release : 06-01-09
Isis Highlights New Clinical Data on Anti-Cancer Antisense Drugs Featured at ASCO
> More Info

Press Release : 05-20-09
Genzyme and Isis Announce that Mipomersen Phase 3 Study in Patients with Homozygous Familial Hypercholesterolemia Met Primary Endpoint
> More Info

 

©1999-2009 Isis Pharmaceuticals, Inc. All Rights Reserved

Isis Pharmaceuticals is a registered trademark of Isis Pharmaceuticals, Inc.
Regulus Therapeutics is a trademark of Regulus Therapeutics Inc.
Ibis T5000™ is a trademark of Ibis Biosciences, Inc.